Octreotide infusion for the treatment of chylothorax in pediatric cardiac intensive care unit

Anadolu Kardiyol Derg. 2005 Dec;5(4):317-8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Cardiac Surgical Procedures / adverse effects
  • Chylothorax / drug therapy*
  • Chylothorax / etiology
  • Chylothorax / mortality
  • Fat Emulsions, Intravenous / therapeutic use
  • Fatal Outcome
  • Female
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Infant
  • Intensive Care Units, Pediatric
  • Male
  • Octreotide / therapeutic use*
  • Parenteral Nutrition, Total
  • Postoperative Complications
  • Treatment Outcome

Substances

  • Fat Emulsions, Intravenous
  • Gastrointestinal Agents
  • Octreotide